Development and Psychometric Testing of a New Short-Form of the Premenstrual Symptoms Questionnaire (PSQ-S)

Overview

Journal Int J Womens Health

Publisher Dove Medical Press

Specialty Gynecology & Obstetrics

Date 2022 Jul 21

PMID 35860717

Authors

Takashi Takeda

Kana Yoshimi

Sayaka Kai

Fumi Inoue

Affiliations

Soon will be listed here.

Abstract

Purpose: The Premenstrual Symptoms Questionnaire (PSQ) is a patient-reported outcome measurement tool for premenstrual symptoms. Although the PSQ is a very useful tool with 14 items to screen for a wide variety of premenstrual symptoms, not everyone will respond to all the questions. Fewer questions would be less burdensome on the respondents. We aimed to develop and analyze the psychometric properties of a short-form of the PSQ (PSQ-S).

Patients And Methods: The study participants were from an earlier study with a sample of 1388 female students. We reanalyzed data collected from 922 students with regular menstrual cycles who completed the PSQ, premenstrual dysphoric disorder (PMDD) scale, Somatic Symptom Scale-8 (SSS-8), and numerical rating scale (NRS) for menstrual pain. First, we selected nine items for the PSQ-S based on the results of the corrected item-total correlation analysis. The PSQ-S was then analyzed for reliability and validity using the classical test theory. Moreover, item response theory was applied to test the psychometric properties of the PSQ-S.

Results: Cronbach's α for the PSQ-S score was 0.93. Principal component factor analysis revealed a one-factor model. Confirmatory factor analysis showed that the one-factor model was a good fit. The PSQ-S total score was strongly correlated with the PSQ total score, PMDD scale score, and SSS-8 score (r=0.978, 0.854, and 0.648, respectively) and moderately correlated with the NRS (r=0.437). Item response theory analyses showed that the constructs and items of the PSQ-S had satisfactory discrimination, difficulty parameters, item information curves, and test information curves. Receiver operating characteristic curve analysis revealed a cut-off score of ≥22 for suspected premenstrual disorders based on the total PSQ-S score.

Conclusion: The PSQ-S, consisting of nine items from the PSQ, had sufficient reliability and validity and could be a convenient assessment tool for premenstrual symptoms in routine clinical practice.

Citing Articles

Validation of the premenstrual symptoms questionnaire among Mongolian nursing school students.

Choijiljav D, Sukhbat T, Ogawa S, Yanjmaa E, Badamdorj O, Saito A BMC Womens Health. 2024; 24(1):661.

PMID: 39710668 PMC: 11664845. DOI: 10.1186/s12905-024-03492-3.

Development and psychometric assessment of a health action process approach (HAPA) inventory for home nutritional behavior among postoperative gastric cancer patients.

Jiang X, Chen J, Yuan X, Chen Y, Sun Q, Zhao H Asia Pac J Oncol Nurs. 2024; 11(10):100569.

PMID: 39286530 PMC: 11402125. DOI: 10.1016/j.apjon.2024.100569.

References

Ware Jr J, Kosinski M, Keller S . A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996; 34(3):220-33. DOI: 10.1097/00005650-199603000-00003. View

Mortola J, Girton L, Beck L, Yen S . Diagnosis of premenstrual syndrome by a simple, prospective, and reliable instrument: the calendar of premenstrual experiences. Obstet Gynecol. 1990; 76(2):302-7. View

Yoshimi K, Shiina M, Takeda T . Lifestyle Factors Associated with Premenstrual Syndrome: A Cross-sectional Study of Japanese High School Students. J Pediatr Adolesc Gynecol. 2019; 32(6):590-595. DOI: 10.1016/j.jpag.2019.09.001. View

Mahfoud Z, Emam R, Anchassi D, Omran S, Alhaj N, Al-Abdulla S . Premenstrual dysphoric disorder in Arab women: Validation and cultural adaptation of the Arabic version of the premenstrual screening tool. Women Health. 2018; 59(6):631-645. DOI: 10.1080/03630242.2018.1539433. View

Borenstein J, Dean B, Leifke E, Korner P, Yonkers K . Differences in symptom scores and health outcomes in premenstrual syndrome. J Womens Health (Larchmt). 2007; 16(8):1139-44. DOI: 10.1089/jwh.2006.0230. View

Takeda T, Kai S, Yoshimi K . Psychometric Testing of the Japanese Version of the Daily Record of Severity of Problems Among Japanese Women. Int J Womens Health. 2021; 13:361-367. PMC: 8020050. DOI: 10.2147/IJWH.S301260. View

Matsudaira K, Oka H, Kawaguchi M, Murakami M, Fukudo S, Hashizume M . Development of a Japanese version of the Somatic Symptom Scale-8: Psychometric validity and internal consistency. Gen Hosp Psychiatry. 2017; 45:7-11. DOI: 10.1016/j.genhosppsych.2016.12.002. View

Endicott J, Nee J, Harrison W . Daily Record of Severity of Problems (DRSP): reliability and validity. Arch Womens Ment Health. 2005; 9(1):41-9. DOI: 10.1007/s00737-005-0103-y. View

Hantsoo L, Epperson C . Allopregnanolone in premenstrual dysphoric disorder (PMDD): Evidence for dysregulated sensitivity to GABA-A receptor modulating neuroactive steroids across the menstrual cycle. Neurobiol Stress. 2020; 12:100213. PMC: 7231988. DOI: 10.1016/j.ynstr.2020.100213. View

10.

Hariri F, Moghaddam-Banaem L, Siah Bazi S, Malehi A, Montazeri A . The Iranian version of the Premenstrual Symptoms Screening Tool (PSST): a validation study. Arch Womens Ment Health. 2013; 16(6):531-7. DOI: 10.1007/s00737-013-0375-6. View

11.

Ware Jr J, Sherbourne C . The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992; 30(6):473-83. View

12.

OBrien P, Backstrom T, Brown C, Dennerstein L, Endicott J, Epperson C . Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus. Arch Womens Ment Health. 2011; 14(1):13-21. PMC: 4134928. DOI: 10.1007/s00737-010-0201-3. View

13.

Sliwerski A, Koszalkowska K . The Influence of Depression on Biased Diagnosis of Premenstrual Syndrome and Premenstrual Dysphoric Disorder by the PSST Inventory. Life (Basel). 2021; 11(11). PMC: 8624424. DOI: 10.3390/life11111278. View

14.

Miyaoka Y, Akimoto Y, Ueda K, Ujiie Y, Kametani M, Uchiide Y . Fulfillment of the premenstrual dysphoric disorder criteria confirmed using a self-rating questionnaire among Japanese women with depressive disorders. Biopsychosoc Med. 2011; 5:5. PMC: 3110105. DOI: 10.1186/1751-0759-5-5. View

15.

Takeda T, Chiba Y . Evaluation of a natural S-equol supplement in treating premenstrual symptoms and the effect of the gut microbiota: An open-label pilot study. Neuropsychopharmacol Rep. 2022; 42(2):127-134. PMC: 9216369. DOI: 10.1002/npr2.12234. View

16.

Youngstrom E . A primer on receiver operating characteristic analysis and diagnostic efficiency statistics for pediatric psychology: we are ready to ROC. J Pediatr Psychol. 2013; 39(2):204-21. PMC: 3936258. DOI: 10.1093/jpepsy/jst062. View

17.

Takeda T, Koga S, Yaegashi N . Prevalence of premenstrual syndrome and premenstrual dysphoric disorder in Japanese high school students. Arch Womens Ment Health. 2010; 13(6):535-7. DOI: 10.1007/s00737-010-0181-3. View

18.

Cohen L, Soares C, Otto M, Sweeney B, F Liberman R, Harlow B . Prevalence and predictors of premenstrual dysphoric disorder (PMDD) in older premenopausal women. The Harvard Study of Moods and Cycles. J Affect Disord. 2002; 70(2):125-32. DOI: 10.1016/s0165-0327(01)00458-x. View

19.

Gehlert S, Song I, Chang C, Hartlage S . The prevalence of premenstrual dysphoric disorder in a randomly selected group of urban and rural women. Psychol Med. 2008; 39(1):129-36. PMC: 2752820. DOI: 10.1017/S003329170800322X. View

20.

Takeda T, Yoshimi K, Yamada K . Psychometric Testing of the Premenstrual Symptoms Questionnaire and the Association Between Perceived Injustice and Premenstrual Symptoms: A Cross-Sectional Study Among Japanese High School Students. Int J Womens Health. 2020; 12:755-763. PMC: 7524195. DOI: 10.2147/IJWH.S269392. View